MASS-FIX may allow identification of patients at risk for light chain amyloidosis before the onset of symptoms.
Kourelis T, Murray DL, Dasari S, Kumar S, Barnidge D, Madden B, Arendt B, Milani P, Merlini G, Ramirez-Alvarado M, Kyle RA, Dispenzieri A.
Kourelis T, et al. Among authors: barnidge d.
Am J Hematol. 2018 Nov;93(11):E368-E370. doi: 10.1002/ajh.25244. Epub 2018 Sep 21.
Am J Hematol. 2018.
PMID: 30105838
Free article.
No abstract available.